- IXCHIQ® was well tolerated by children aged one to eleven years regardless of the dose or previous chikungunya infection (CHIKV)
- Antibody levels remained high after twelve months in … [+11239 chars]
Read Full Story
- Home
- Kenya News
- Valneva Reports Positive Final Phase 2 Antibody Persistence and Safety Results in Children for its Chikungunya Vaccine IXCHIQ®
Related Post
Brains Behind Nairobi’s Multi Million Retail And Entertainment Hub, Signature Mall
Signature Mall is a modern mixed-use retail and entertainment complex located along Mombasa Road in Nairobi, about 25 kilometres south…
How banks can help to improve their customers’ tax compliance
Hundreds of locals await service at the KRA Mombasa Service Center. [File, Standard] Discussions on tax compliance in Kenya frequently…
Microsoft’s $1 Billion Kenya Data Center Stalled Over Power Capacity Disagreements, Officials Say
Project Halted Over Power Requirements A $1 billion data center planned by Microsoft and Abu Dhabi-based artificial intelligence firm G42…
FG made emergency vaccine requests to battle cholera – Report
The Federal Government has made four emergency requests to the International Coordinating Group on Vaccine Provision for cholera vaccines as…
Giant society turns to land lease to grow revenues
Muka Mukuu Farmers Cooperative Society chairman, Dominic Nthwao addresses the press after chairing an AGM at the society headquarters in…